The U.S. Defense Advanced Research Projects Agency (DARPA) has made the creation of upper-limb prosthesis, artificial arms and hands that allow for sensory feedback a top priority--it's backing 8 research organizations to do so.
ElectRx, DARPA's Electrical Prescriptions program, put out a call Thursday for research proposals to develop neuromodulation capabilities that will "maximize the immunological, physical and mental health" of military service members and veterans.
Inovio Pharmaceuticals, AstraZeneca's MedImmune and the University of Pennsylvania have joined forces to study influenza and antibiotic-resistant bacteria, drawing on $12.2 million in federal funds.
The Defense Advanced Research Projects Agency awarded Harvard University engineers up to $2.9 billion to develop a robotic suit to make walking easier for soldiers and potentially civilians with disabilities, the university announced today.
The U.S. Department of Defense is pursuing the creation of brain implants that could treat brain injury-related memory loss, an initiative that could benefit companies ranging from Medtronic to General Electric and more.
Vaccines have basically worked the same way for decades. A pathogen antigen is isolated, used as the basis of a vaccine and administered to the patient. The Pentagon thinks there might be a better way of doing things, and it has tasked Pfizer with investigating its hunch.
The U.S. Department of Defense is launching a $70 million project involving the use of a brain monitoring implant to help soldiers better manage depression, stress and other related conditions.
President Barack Obama plans to roll out a highly anticipated brain mapping project today, providing details about the ambitious initiative to uncover mysteries about complex brain functions that could lead to new therapies for Alzheimer's and Parkinson's diseases.
A unit of the U.S. Department of Defense has challenged the Foldit video gamers to craft proteins in a virtual online setting that bind to pathogens in the blood, to bolster research of sepsis treatments.
It will come as no surprise to anyone in the business of drug development and translational research to hear that animal studies suffer from severe shortcomings. The traditional mouse study often can't detect the kind of simple toxicities that will scuttle a program later on.